• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Acta Ophthalmol. Evaluation of ocular symptoms and tropism of SARS-CoV-2 in patients confirmed with COVID-19

tetano

Editor, Senior Moderator
Acta Ophthalmol. 2020 Apr 26. doi: 10.1111/aos.14445. [Epub ahead of print]
Evaluation of ocular symptoms and tropism of SARS-CoV-2 in patients confirmed with COVID-19.


Hong N[SUP]#[/SUP][SUP]1[/SUP], Yu W[SUP]#[/SUP][SUP]1[/SUP], Xia J[SUP]1[/SUP], Shen Y[SUP]1[/SUP], Yap M[SUP]2[/SUP], Han W[SUP]1[/SUP].

Author information




Abstract

PURPOSE:

The SARS-CoV-2 RNA has been detected in tears and conjunctival samples from infected individuals. Conjunctivitis is also reported in a small number of cases. We evaluated ocular symptoms and ocular tropism of SARS-CoV-2 in a group of patients with COVID-19.
METHOD:

Fifty-six patients infected with SARS-CoV-2 were recruited as subjects. Relevant medical histories were obtained from the electronic medical record system. Ocular history and ocular symptoms data were obtained by communicating directly with the subjects. The Ocular Surface Disease Index (OSDI) and Salisbury Eye Evaluation Questionnaire (SEEQ) were used to assess the anterior ocular surface condition before and after the onset of disease.
RESULTS:

Patients classified as severe COVID-19 cases were more likely to have hypertension compared to mild cases (p = 0.035). Of the 56 subjects, thirteen patients (23%) were infected in Wuhan, 32 patients (57%) were community-infected, 10 patients (18%) were unknown origin, 1 (2%) was a physician likely infected by a confirmed patient. Three patients wore face mask with precaution when contacting the confirmed patients. Fifteen (27%) had aggravated ocular symptoms, of which 6 (11%) had prodromal ocular symptoms before disease onset. The differences in mean scores of OSDI questionnaire and SEEQ between before and after onset of COVID-19 were all significant (p < 0.05 for both).
CONCLUSIONS:

Ocular symptoms are relatively common in COVID-19 disease and may appear just before the onset of respiratory symptoms. Our data provided the anecdotal evidences of transmission of SARS-CoV-2 via ocular surface.
? 2020 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.



KEYWORDS:

conjunctivitis; coronavirus disease 2019; dry eye; severe acute respiratory syndrome coronavirus


PMID:32336042DOI:10.1111/aos.14445
 
Back
Top Bottom